Literature DB >> 6896153

Plasma protein profiles and prognosis in gastric cancer.

S A Rashid, J O'Quigley, A T Axon, E H Cooper.   

Abstract

In 104 patients with gastric cancer the serum proteins carcinoembryonic antigen (CEA), C-reactive protein (CRP), alpha 1-acid glycoprotein (AGP) (orosomucoid) and alpha 1-antichymotrypsin (ACT) were measured pre-operatively. The estimated median survival of patients with both raised CEA and ACT was only 5 weeks in contrast to 64 weeks for those with both proteins normal. An intermediary group with one of these proteins raised and the other normal had an estimated median survival of 15 weeks. Similar results were obtained by considering a combination of CEA with either AGP or CRP. For these data the results were not explicable in terms of associations between survival time and patient's age, stage, operative procedure, histological classification or site of primary tumour.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6896153      PMCID： PMC2010918          DOI： 10.1038/bjc.1982.66

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  23 in total

1.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

2.  Carcinoma of the stomach.

Authors:  B F SWYNNERTON; S C TRUELOVE
Journal:  Br Med J       Date:  1952-02-09

3.  A co-operative international study of gastric cancer (under the auspices of the International Federation of Surgical Colleges).

Authors:  G Lundh; J I Burn; G Kolig; C A Richard; J W Thomson; P J van Elk; J Oszacki
Journal:  Ann R Coll Surg Engl       Date:  1974-05       Impact factor: 1.891

4.  Results of treatment of stomach cancer. An appraisal of efforts for more extensive surgery and a rort of 1,983 cases.

Authors:  V A Gilbertsen
Journal:  Cancer       Date:  1969-06       Impact factor: 6.860

5.  Carcinoembryonic antigen in breast cancer patients: serum levels and disease progress.

Authors:  A M Steward; D Nixon; N Zamcheck; A Aisenberg
Journal:  Cancer       Date:  1974-05       Impact factor: 6.860

6.  C.E.A. in gastric cancer.

Authors:  J G Freeman; A L Latner; G A Turner; C W Venables
Journal:  Lancet       Date:  1979-01-27       Impact factor: 79.321

7.  Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer.

Authors:  H J Wanebo; B Rao; C M Pinsky; R G Hoffman; M Stearns; M K Schwartz; H F Oettgen
Journal:  N Engl J Med       Date:  1978-08-31       Impact factor: 91.245

8.  Prognostic significance of serum proteins in invasive bladder cancer. A preliminary report of the E.O.R.T.C. Urological Group.

Authors:  J O'Quigley; S Haworth; E H Cooper; W Haije; B van der Werf-Messing; B Richards; M R Robinson
Journal:  Eur J Cancer       Date:  1981-02       Impact factor: 9.162

9.  Carcinoembryonic antigen in 228 patients with carcinoma of the lung.

Authors:  R G Vincent; T M Chu; T B Fergen; M Ostrander
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

10.  Carcinoembryonic antigen and prognosis after radical surgery for lung cancer: immunocytochemical localization and serum levels.

Authors:  C H Ford; H J Stokes; C E Newman
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640
View more
  11 in total

1.  Retinol-binding protein, acute phase reactants and Helicobacter pylori infection in patients with gastric adenocarcinoma.

Authors:  Nicolas Tsavaris; Christos Kosmas; Petros Kopterides; Dimitrios Tsikalakis; Hlias Skopelitis; Fotini Sakelaridi; Nikitas Papadoniou; Michalis Tzivras; Vasilios Balatsos; Christos Koufos; Athanasios Archimandritis
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

2.  The acute-phase protein response in parasite infection. Nippostrongylus brasiliensis and Trichinella spiralis in the rat.

Authors:  A W Stadnyk; H Baumann; J Gauldie
Journal:  Immunology       Date:  1990-04       Impact factor: 7.397

3.  Pretreatment serum C-reactive protein level predicts poor prognosis in patients with hepatocellular carcinoma.

Authors:  Akiyoshi Kinoshita; Hiroshi Onoda; Keiko Takano; Nami Imai; Chisato Saeki; Nao Fushiya; Yoshinari Miyakawa; Hirokazu Nishino; Hisao Tajiri
Journal:  Med Oncol       Date:  2012-03-30       Impact factor: 3.064

4.  Preoperative elevation of serum C-reactive protein as an independent prognostic indicator for gastric cancer.

Authors:  Tadahiro Nozoe; Tomohiro Iguchi; Eisuke Adachi; Akito Matsukuma; Takahiro Ezaki
Journal:  Surg Today       Date:  2011-03-23       Impact factor: 2.549

5.  Persistent elevated C-reactive protein after treatment is an independent marker of a poor prognosis in patients with hepatocellular carcinoma.

Authors:  N Imai; A Kinoshita; H Onoda; A Iwaku; M Oishi; K Tanaka; N Fushiya; K Koike; H Nishino; H Tajiri
Journal:  Clin Transl Oncol       Date:  2012-12-21       Impact factor: 3.405

6.  Prognostic role of host cyclooxygenase and cytokine genotypes in a Caucasian cohort of patients with gastric adenocarcinoma.

Authors:  María Asunción García-González; David Nicolás-Pérez; Angel Lanas; Luis Bujanda; Patricia Carrera; Rafael Benito; Mark Strunk; Federico Sopeña; Santos Santolaria; Elena Piazuelo; Pilar Jiménez; Rafael Campo; Jesús Espinel; Marisa Manzano; Fernando Geijo; María Pellisé; Ferrán González-Huix; Jorge Espinós; Manuel Zaballa; Llúcia Titó; Luis Barranco; Roberto Pazo; Enrique Quintero
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

7.  Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer.

Authors:  D A C Deans; S J Wigmore; H Gilmour; S Paterson-Brown; J A Ross; K C H Fearon
Journal:  Br J Cancer       Date:  2006-11-07       Impact factor: 7.640

8.  Identification of differentially expressed serum proteins in gastric adenocarcinoma.

Authors:  Yashwanth Subbannayya; Sartaj Ahmad Mir; Santosh Renuse; Srikanth S Manda; Sneha M Pinto; Vinuth N Puttamallesh; Hitendra Singh Solanki; H C Manju; Nazia Syed; Rakesh Sharma; Rita Christopher; M Vijayakumar; K V Veerendra Kumar; T S Keshava Prasad; Girija Ramaswamy; Rekha V Kumar; Aditi Chatterjee; Akhilesh Pandey; Harsha Gowda
Journal:  J Proteomics       Date:  2015-05-05       Impact factor: 4.044

9.  Impact of serum C-reactive protein level on the prognosis of patients with hepatocellular carcinoma undergoing TACE.

Authors:  Chung Hwan Jun; Ho Seok Ki; Ki Hoon Lee; Kang Jin Park; Seon Young Park; Sung Bum Cho; Chang Hwan Park; Young Eun Joo; Hyun Soo Kim; Sung Kyu Choi; Jong Sun Rew
Journal:  Clin Mol Hepatol       Date:  2013-03-25

10.  The role of a questionnaire and four biochemical markers to detect cancer risk in a symptomatic population.

Authors:  E M Chisholm; R J Marshall; D Brown; E H Cooper; G R Giles
Journal:  Br J Cancer       Date:  1986-01       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.